FDA and CMS Sign Memorandum of Understanding to Enhance Collaboration

Summary

The US Food and Drug Administration (FDA) and the Centers for Medicare and Medicaid Services (CMS) have agreed to work together to improve information sharing and collaboration, aiming to enhance the efficiency of their joint efforts in product analysis and evaluation.